William Blair Weighs in on K2M Group Holdings Inc’s FY2017 Earnings (KTWO)

K2M Group Holdings Inc (NASDAQ:KTWO) – Stock analysts at William Blair lowered their FY2017 EPS estimates for shares of K2M Group in a report issued on Monday. William Blair analyst K. Krum now forecasts that the medical device company will post earnings per share of ($0.87) for the year, down from their prior estimate of ($0.86). William Blair currently has a “Outperform” rating on the stock. William Blair also issued estimates for K2M Group’s Q1 2018 earnings at ($0.20) EPS, Q2 2018 earnings at ($0.15) EPS, Q3 2018 earnings at ($0.11) EPS, Q4 2018 earnings at ($0.06) EPS and FY2018 earnings at ($0.52) EPS.

KTWO has been the topic of several other reports. Needham & Company LLC dropped their price objective on K2M Group from $27.00 to $26.00 and set a “strong-buy” rating on the stock in a report on Thursday, November 2nd. ValuEngine lowered K2M Group from a “hold” rating to a “sell” rating in a report on Tuesday, October 10th. BidaskClub lowered K2M Group from a “buy” rating to a “hold” rating in a report on Wednesday, December 6th. Oppenheimer reissued a “buy” rating and issued a $24.00 price objective on shares of K2M Group in a report on Friday, November 10th. Finally, Barclays reissued a “buy” rating and issued a $25.00 price objective on shares of K2M Group in a report on Tuesday. Two analysts have rated the stock with a sell rating, two have given a hold rating and nine have given a buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of $24.50.

Shares of K2M Group (KTWO) opened at $20.20 on Wednesday. The company has a debt-to-equity ratio of 0.29, a current ratio of 3.06 and a quick ratio of 1.67. K2M Group has a 1-year low of $16.44 and a 1-year high of $25.99. The company has a market capitalization of $875.24, a P/E ratio of -21.04 and a beta of 1.34.

K2M Group (NASDAQ:KTWO) last issued its quarterly earnings data on Wednesday, November 1st. The medical device company reported ($0.20) EPS for the quarter, missing the consensus estimate of ($0.19) by ($0.01). K2M Group had a negative net margin of 16.22% and a negative return on equity of 16.02%. The business had revenue of $62.65 million during the quarter, compared to analyst estimates of $62.69 million. During the same period in the previous year, the business posted ($0.19) earnings per share. The firm’s revenue for the quarter was up 5.6% on a year-over-year basis.

Large investors have recently modified their holdings of the company. Cubist Systematic Strategies LLC boosted its stake in shares of K2M Group by 7,765.0% in the third quarter. Cubist Systematic Strategies LLC now owns 4,719 shares of the medical device company’s stock worth $100,000 after acquiring an additional 4,659 shares during the last quarter. Rockefeller Financial Services Inc. purchased a new position in K2M Group during the third quarter worth approximately $105,000. BNP Paribas Arbitrage SA lifted its position in K2M Group by 5,175.3% during the second quarter. BNP Paribas Arbitrage SA now owns 4,484 shares of the medical device company’s stock worth $109,000 after buying an additional 4,399 shares in the last quarter. Dorsey & Whitney Trust CO LLC purchased a new position in K2M Group during the second quarter worth approximately $211,000. Finally, Trexquant Investment LP purchased a new position in K2M Group during the third quarter worth approximately $223,000. 97.95% of the stock is currently owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION NOTICE: “William Blair Weighs in on K2M Group Holdings Inc’s FY2017 Earnings (KTWO)” was first published by American Banking News and is the property of of American Banking News. If you are viewing this piece of content on another website, it was illegally stolen and reposted in violation of international copyright & trademark laws. The legal version of this piece of content can be accessed at https://www.americanbankingnews.com/2018/01/10/william-blair-weighs-in-on-k2m-group-holdings-incs-fy2017-earnings-ktwo.html.

K2M Group Company Profile

K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.

Receive News & Ratings for K2M Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply